These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18816606)

  • 1. Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2.
    Pisani V; Panico MB; Terracciano C; Bonifazi E; Meola G; Novelli G; Bernardi G; Angelini C; Massa R
    Muscle Nerve; 2008 Nov; 38(5):1405-1411. PubMed ID: 18816606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2.
    Vihola A; Bassez G; Meola G; Zhang S; Haapasalo H; Paetau A; Mancinelli E; Rouche A; Hogrel JY; Laforêt P; Maisonobe T; Pellissier JF; Krahe R; Eymard B; Udd B
    Neurology; 2003 Jun; 60(11):1854-7. PubMed ID: 12796551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy.
    Bassez G; Chapoy E; Bastuji-Garin S; Radvanyi-Hoffman H; Authier FJ; Pellissier JF; Eymard B; Gherardi RK
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):319-25. PubMed ID: 18379436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
    Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
    Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.
    Vihola A; Bachinski LL; Sirito M; Olufemi SE; Hajibashi S; Baggerly KA; Raheem O; Haapasalo H; Suominen T; Holmlund-Hampf J; Paetau A; Cardani R; Meola G; Kalimo H; Edström L; Krahe R; Udd B
    Acta Neuropathol; 2010 Apr; 119(4):465-79. PubMed ID: 20066428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2).
    Salvatori S; Furlan S; Fanin M; Picard A; Pastorello E; Romeo V; Trevisan CP; Angelini C
    Neurol Sci; 2009 Jun; 30(3):185-92. PubMed ID: 19326042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
    Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
    Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
    Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes.
    Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C
    Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant fiber atrophy and fiber type disproportion in early ullrich disease.
    Schessl J; Goemans NM; Magold AI; Zou Y; Hu Y; Kirschner J; Sciot R; Bönnemann CG
    Muscle Nerve; 2008 Sep; 38(3):1184-91. PubMed ID: 18720506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle.
    Ikezoe K; Nakamori M; Furuya H; Arahata H; Kanemoto S; Kimura T; Imaizumi K; Takahashi MP; Sakoda S; Fujii N; Kira J
    Acta Neuropathol; 2007 Nov; 114(5):527-35. PubMed ID: 17661063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.
    Renna LV; Cardani R; Botta A; Rossi G; Fossati B; Costa E; Meola G
    Eur J Histochem; 2014 Oct; 58(4):2444. PubMed ID: 25578974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
    Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
    J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcolemmal excitability in the myotonic dystrophies.
    Boland-Freitas R; Lee J; Howells J; Liang C; Corbett A; Nicholson G; Ng K
    Muscle Nerve; 2018 Apr; 57(4):595-602. PubMed ID: 28881011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2).
    Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.